MEDVASC – Réversion AOD : case départ !
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
LIVE WEBINAR: Wednesday, May 8, 2024 | 5:00 PM – 6:00 PM Eastern Time (ET) Register for this complimentary event with the “Register Now” button…
Monday, May 6, 2024, 5:00 PM – 6:00 PM Eastern Time Register for this complimentary event with the “Register Now” button above, which will take…
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the…
PURPOSE Crenolanib is a second-generation tyrosine kinase inhibitor with activity against FLT3-ITD– and TKD-mutant AML. We conducted a trial of crenolanib plus intensive chemotherapy in…
Research To Practice requires users to log in to view educational content. All content is available without
Hide glossary Study record managers: ref er to the Data Element Definitions if submitting registration or results information.
👉Apoya el Periodismo Independiente a Través de: 👉Un Cafecito☕ https://www.buymeacoffee.com/julioseroa 👉 Vía PayPal https://bit.ly/34cnIBR 👉Clic UNIRME…
A video from Ayalew Tefferi (as part of Indy Hematology Review), posted on Apr 24, 2024.
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
On April 16 the Minister of Finance delivered the 2024 Federal Budget in the House of Commons. The budget contained a long list of new…